[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100639377":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":34,"locations":39,"responsibleParty":54,"collaborators":25,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":25,"eligibilityCriteria":63,"healthyVolunteers":59,"sex":64,"minAge":65,"maxAge":66,"enrollmentInfo":67,"targetDuration":25,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":78,"overallStatus":41,"whyStopped":25,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Alexandria University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"group 1","ACTIVE_COMPARATOR","patients will receive bilateral ESP block",[13],"Other: bilateral ESP block",{"label":15,"type":16,"description":17,"interventionNames":18},"group 2","EXPERIMENTAL","patients will receive bilateral M-TAPA block",[19],"Other: bilateral M-TAPA block",[21,26],{"type":6,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"bilateral ESP block","bilateral ESP block with injection of 20 ml 0.25% bupivacaine.",[9],null,{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"bilateral M-TAPA block","bilateral M-TAPA block with injection of 20 ml of 0.25% bupivacaine.",[15],[31],{"name":32,"affiliation":5,"role":33},"sarah m elgamal, MD","PRINCIPAL_INVESTIGATOR",[35],{"name":32,"role":36,"phone":37,"phoneExt":25,"email":38},"CONTACT","01005496440","sarahelgamal1990@yahoo.com",[40],{"facility":5,"status":41,"city":42,"state":25,"zip":25,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"RECRUITING","Alexandria","Egypt","EG",{"type":46,"coordinates":47},"Point",[48,49],29.91582,31.20176,{"lat":49,"lon":48},[52,53],{"name":32,"role":36,"phone":37,"phoneExt":25,"email":38},{"name":32,"role":33,"phone":25,"phoneExt":25,"email":25},{"type":33,"investigatorFullName":55,"investigatorTitle":56,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"sarah mohamed","lecturer","100639377","erector-spina-plane-block-versus-modified-thoracoabdominal-nerve-block-after-laparoscopic-cholecystectomy-100639377",false,"NCT07624058","Erector Spina Plane Block Versus Modified Thoracoabdominal Nerve Block After Laparoscopic Cholecystectomy","Erector Spinae Plane Block Versus Modified Thoracoabdominal Nerve Block For Pain Control After Laparoscopic Cholecystectomy","Inclusion Criteria:\n\n* Age: between 30 - 65\n* American Society of Anaesthesiologists physical status: I- III\n* Body mass index: 18-35 kg.m-2\n\nExclusion Criteria:\n\n* Patient Refusal\n* Allergy to local anaesthetic agents.\n* Skin infection at the site of injection.\n* Coagulopathy.\n* Diabetes Mellitus","ALL","30 Years","65 Years",{"count":68,"type":69},50,"ESTIMATED","INTERVENTIONAL",[72],"NA","direct comparisons between ESPB and M-TAPA for postoperative analgesia after LC remain limited. This is an important area of clinical interest because the two blocks differ significantly in their anatomical targets, mechanism of analgesia, and likely dermatomal coverage. The ESPB provides analgesia through paravertebral spread affecting both dorsal and ventral rami, thereby offering posterior and visceral pain relief, whereas M-TAPA directly targets the thoracoabdominal nerves, resulting in better anterior and lateral abdominal wall analgesia. Understanding which technique offers superior or more balanced analgesia could help to optimise regional anaesthesia strategies in LC and to improve patient outcomes.",[75,76,77],"Erector Spinae Block","Modified Thoracoabdominal Nerve Block","Laparoscopic Cholecystectomy",[79,80],"pain control","erector spinae block","2026-05-29",{"date":83,"type":84},"2026-06-03","ACTUAL",{"date":86,"type":84},"2026-04-01",{"date":88,"type":69},"2027-03-01",{"name":5,"class":6},1]